CONSENSUS B Tat-6 is a consensus-derived peptide applied to investigations of Tat-mediated transcription and nucleic binding interfaces. Its structure supports studies of regulatory determinants and ligand accessibility. Researchers employ it for evaluating motif conservation. The fragment enhances mapping of functional Tat sequences.
CAT No: H09443
1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More